R&d
We are committed to developing products that improve options and outcomes for women's health care
The building blocks of the MedRing as a Platform
Drug Delivery
Exploratory Phase
Pre-Clinical Development Phase
Clinical Phase II
Clinical Phase III
Clinical Phase II
Overactive bladder (oxybutynin)
Pre-Clinical Development Phase
Hot flush adjuvans, post-breast cancer surgery (oxybutynin)
Hot flush therapy post-menopause
Diabetes
Endometriosis
Parkinson’s tremors
Exploratory Phase
Smoking cessation
Diagnostics
Exploratory Phase
Pre-Clinical Development Phase
Clinical Phase II
Clinical Phase III
Clinical Phase II
Compliance in drug delivery
Pre-Clinical Development Phase
Tumor markers
Post-operative pressure monitoring
Exploratory Phase
Cycle monitoring
Ovulation detection
Glucose sensor
Overactive bladder monitoring
Other
Exploratory Phase
Pre-Clinical Development Phase
Clinical Phase II
Clinical Phase III
Clinical Phase II
Dummy ring suitability study
See what we're up to
Check out our most recent updates and milestones to see how close we are to launching the MedRing.
Get in touch
Office
Leiden Bio Science Park – BioPartner 1
Address
J.H. Oortweg 21
2333 CH Leiden
The Netherlands